Labbit Goes All-In on LIMS Platform, Retires Semaphore Solutions Brand
After a decade of implementing laboratory systems for regulated labs, company consolidates under the Labbit name to focus entirely on its modern LIMS platform VANCOUVER,... Read more.
Ontinue Opens New Headquarters in Zurich, Strengthening Commitment to European Growth and Innovation
New Office Reflects Continued Investment in Talent, Customers, and Security Excellence Across DACH and Beyond ZURICH, April 20, 2026 /PRNewswire/ — Ontinue,... Read more.
CAMSO Construction Enters Key European Markets with Strong On-Ground Readiness
PARIS, April 20, 2026 /PRNewswire/ — CAMSO Construction has announced its market readiness across key European markets – France, Italy, Spain, and Portugal,... Read more.
AlphaGen Therapeutics to Present Preclinical Studies of Two Next-Generation Alpha Therapies at AACR 2026
SHANGHAI, April 20, 2026 /PRNewswire/ — AlphaGen Therapeutics (AlphaGen), a biopharmaceutical company that focuses on developing next-generation targeted alpha... Read more.
AlphaGen Therapeutics to Present Preclinical Studies of Two Next-Generation Alpha Therapies at AACR 2026
SHANGHAI, April 20, 2026 /PRNewswire/ — AlphaGen Therapeutics (AlphaGen), a biopharmaceutical company that focuses on developing next-generation targeted alpha... Read more.
BingX Reports Strong Q1 2026 Growth as AI Users Surpass 5 Million and TradFi Hits 50% of Volume
Q1 2026 Highlights: BingX launched the TradFi Market, delivering a multi-asset suite of stocks, indices, commodities, and forex, with over 100 traditional assets... Read more.
XTransfer Export PMI: Emerging Markets Drive Growth, High-End Upgrading Opportunities Stand Out
GUANGZHOU, China, April 20, 2026 /PRNewswire/ — XTransfer, the World’s Leading B2B Cross-Border Trade Payment Platform, released its latest figures at... Read more.
BingX Reports Strong Q1 2026 Growth as AI Users Surpass 5 Million and TradFi Hits 50% of Volume
Q1 2026 Highlights: BingX launched the TradFi Market, delivering a multi-asset suite of stocks, indices, commodities, and forex, with over 100 traditional assets... Read more.
AlphaGen Therapeutics to Present Preclinical Studies of Two Next-Generation Alpha Therapies at AACR 2026
SHANGHAI, April 20, 2026 /PRNewswire/ — AlphaGen Therapeutics (AlphaGen), a biopharmaceutical company that focuses on developing next-generation targeted alpha... Read more.
New Combination Therapy for Advanced Small Cell, Lung Cancer Approved in Australia and Singapore
ZEPZELCA® (lurbinectedin), in combination with atezolizumab (Tecentriq®), is approved for use in Australia and Singapore as a first-line maintenance treatment... Read more.